Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Clinical Pharmacology
|
April 29, 2014
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis
Yanli Zhao, Merit E Cudkowicz, Jeremy M Shefner, et al.
Muscle & Nerve
|
August 23, 2015
A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies
Michael S Cartwright, Leah P Griffin, Hugh Dowlen, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
June 8, 2012
Electrical impedance myography as a biomarker to assess ALS progression
Seward B Rutkove, James B Caress, Michael S Cartwright, et al.
Plos One
|
April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis
James D Berry, Jeremy M Shefner, Robin Conwit, et al.
Plos One
|
May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial
Vincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 5, 2016
Defining SOD1 ALS natural history to guide therapeutic clinical trial design
Taha Bali, Wade Self, Jingxia Liu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
The New England Journal of Medicine
|
September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve
|
October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
JAMA
|
March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, Jeremy M Shefner, Björn Oskarsson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Clinical Pharmacology
|
April 29, 2014
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis
Yanli Zhao, Merit E Cudkowicz, Jeremy M Shefner, et al.
Muscle & Nerve
|
August 23, 2015
A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies
Michael S Cartwright, Leah P Griffin, Hugh Dowlen, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
June 8, 2012
Electrical impedance myography as a biomarker to assess ALS progression
Seward B Rutkove, James B Caress, Michael S Cartwright, et al.
Plos One
|
April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis
James D Berry, Jeremy M Shefner, Robin Conwit, et al.
Plos One
|
May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial
Vincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 5, 2016
Defining SOD1 ALS natural history to guide therapeutic clinical trial design
Taha Bali, Wade Self, Jingxia Liu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
The New England Journal of Medicine
|
September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve
|
October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
JAMA
|
March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, Jeremy M Shefner, Björn Oskarsson, et al.
Page
of 9